37 results on '"Kerbel, Robert S."'
Search Results
2. ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth
3. On coalescent angiogenesis and the remarkable flexibility of blood vessels
4. Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1
5. Variable impact of three different antiangiogenic drugs alone or in combination with chemotherapy on multiple bone marrow-derived cell populations involved in angiogenesis and immunity
6. Vessel co-option in cancer
7. Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease
8. Preclinical impact of high dose intermittent antiangiogenic tyrosine kinase inhibitor pazopanib in intrinsically resistant tumor models
9. Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer
10. Consensus guidelines for the use and interpretation of angiogenesis assays
11. Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents
12. Preliminary Investigation of Focused Ultrasound-Facilitated Drug Delivery for the Treatment of Leptomeningeal Metastases
13. Anti-VEGF therapy reduces intestinal inflammation in Endoglin heterozygous mice subjected to experimental colitis
14. Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer
15. Preclinical analysis of resistance and cross-resistance to low-dose metronomic chemotherapy
16. Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment
17. Strategies for Improving the Clinical Benefit of Antiangiogenic Drug Based Therapies for Breast Cancer
18. Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers
19. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing
20. The anti-angiogenic basis of metronomic chemotherapy
21. Radiation resistance of human melanoma analysed by retroviral insertional mutagenesis reveals a possible role for dopachrome tautomerase
22. Possible Mechanisms of Acquired Resistance to Anti-angiogenic Drugs: Implications for the Use of Combination Therapy Approaches
23. Lineage-specific Mechanism of Drug and Radiation Resistance in Melanoma Mediated by Tyrosinase-related Protein 2
24. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner
25. Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications
26. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma
27. What is the Optimal Rodent Model for Anti-tumor Drug Testing?
28. The dormant in vivo phenotype of early stage primary human melanoma: termination by overexpression of vascular endothelial growth factor
29. Establishing a Link between Oncogenes and Tumor Angiogenesis
30. Growth advantage (“clonal dominance”) of metastatically competent tumor cell variants expressed under selective two- or three-dimensional tissue culture conditions
31. Potentiation of growth suppression and modulation of the antigenic phenotype in human melanoma cells by the combination of recombinant human fibroblast and immune interferons
32. Commentaries on tumor angiogenesis: an introduction
33. Monoclonal Antibodies in Cancer Therapy: An Overview
34. Rodent Tumor Models for Anti-cancer Drug Testing: An Overview
35. Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants
36. On a possible epigenetic mechanism(s) of tumor cell heterogeneity: The role of DNA methylation
37. Immunology of metastasis: Can the immune response cope with disseminated tumor?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.